Results 1 to 10 of about 30,879 (201)

Pulmonary diffusing capacity and dyspnoea following COVID-19: Insights from multicentre datasetsMendeley Data [PDF]

open access: goldData in Brief
Pulmonary complications remain a significant challenge for COVID-19 survivors, necessitating advanced diagnostic approaches for long-term assessment.
Gerald S. Zavorsky   +11 more
doaj   +3 more sources

Pulmonary diffusing capacity for carbon monoxide and nitric oxide after COVID‐19: A prospective cohort study (the SECURe study) [PDF]

open access: diamondExperimental Physiology
Many patients exhibit persistently reduced pulmonary diffusing capacity after coronavirus disease 2019 (COVID‐19). In this study, dual test gas diffusing capacity for carbon monoxide and nitric oxide (DL,CO,NO) metrics and their relationship to disease ...
Anna Agnes Lytzen   +12 more
doaj   +4 more sources

Risk Factors Associated with Impairment in Pulmonary Diffusing Capacity among Patients with Noncystic Fibrosis Bronchiectasis [PDF]

open access: yesCanadian Respiratory Journal, 2022
This study aims to investigate the risk factors associated with impaired pulmonary diffusing capacity among patients with noncystic fibrosis bronchiectasis (NCFB) and compare the predictive value of several scoring systems for the impairment in these ...
Kaijun Zhang   +8 more
doaj   +2 more sources

The need for race-specific reference equations for pulmonary diffusing capacity for nitric oxide [PDF]

open access: yesBMC Pulmonary Medicine, 2021
Background Few reference equations exist for healthy adults of various races for pulmonary diffusing capacity for nitric oxide (DLNO). The purpose of this study was to collect pilot data to demonstrate that race-specific reference equations are needed ...
Gerald Stanley Zavorsky   +4 more
doaj   +2 more sources

Interpretable machine-learning model for Predicting the Convalescent COVID-19 patients with pulmonary diffusing capacity impairment [PDF]

open access: yesBMC Medical Informatics and Decision Making, 2023
Introduction The COVID-19 patients in the convalescent stage noticeably have pulmonary diffusing capacity impairment (PDCI). The pulmonary diffusing capacity is a frequently-used indicator of the COVID-19 survivors’ prognosis of pulmonary function, but ...
Fu-qiang Ma   +8 more
doaj   +2 more sources

Dual test gas pulmonary diffusing capacity in patients with idiopathic scoliosis 40 years after diagnosis [PDF]

open access: yesExperimental Physiology
There is limited knowledge on diffusing capacity in scoliosis patients. It remains to be determined if impaired pulmonary diffusing capacity is mostly influenced by reduced alveolar–capillary membrane diffusing capacity (DM, CO), reduced pulmonary ...
Rie S. Thomsen   +8 more
doaj   +2 more sources

Loss of alveolar membrane diffusing capacity and pulmonary capillary blood volume in pulmonary arterial hypertension

open access: goldRespiratory Research, 2013
Background Reduced gas transfer in patients with pulmonary arterial hypertension (PAH) is traditionally attributed to remodeling and progressive loss of pulmonary arterial vasculature that results in decreased capillary blood volume available for gas ...
Farha Samar   +6 more
doaj   +2 more sources

Pulmonary diffusing capacity to nitric oxide and carbon monoxide during exercise and in the supine position: a test-retest reliability study. [PDF]

open access: diamondExp Physiol, 2023
Madsen AC   +12 more
europepmc   +3 more sources

Prognostic implication of 1-year decline in diffusing capacity in newly diagnosed idiopathic pulmonary fibrosis [PDF]

open access: goldScientific Reports
The progression of idiopathic pulmonary fibrosis (IPF) is assessed through serial monitoring of forced vital capacity (FVC). Currently, data regarding the clinical significance of longitudinal changes in diffusing capacity for carbon monoxide (DLCO) is ...
Hyeonsu Lee   +5 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy